Tiziana Life Sciences Ltd (NASDAQ:TLSA) said its intranasal drug foralumab reduced brain inflammation and was safe in a mid-stage trial in patients with non-active secondary progressive multiple ...

After helping launch a blockbuster Roche and Genentech therapy, Erik Lundgren is betting that Immunic's experimental drug can address persistent gaps in MS care, with pivotal trial results approaching ...

Trial data suggest a single infusion of the experimental CAR T-cell therapy zola-cel may stabilize disability in relapsing or ...

By Dennis Thompson HealthDay ReporterFRIDAY, Oct. 16, 2026 (HealthDay News) — Therapy targeting the immune system’s B cells might offer better odds against relapses in the early stages of multiple ...

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective coating around nerves, which gets damaged in multiple sclerosis (MS) causing ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, Oct 23 (Reuters) - Swiss drugmaker Novartis' oral multiple sclerosis ...

Austin, United States, Sept. 01, 2026 (GLOBE NEWSWIRE)-- According to SNS Insider, The Multiple Sclerosis Drugs Market was valued at USD 21.70 Billion in 2025 and is expected to reach USD 52.82 ...

Medicare drug plans are increasingly excluding coverage of new specialty drugs that treat complex conditions like cancers and autoimmune diseases. New research from the USC Schaeffer Center shows how ...

That includes older drugs like teriflunomide, which was approved in 2012. For those in Medicare Advantage drug plans, having broader formulary coverage was associated with 8–12% lower odds of MS ...

HHS unveiled a new Alzheimer's and dementia plan in Fort Lauderdale focused on prevention and early detection. Here is what is promised and proven. Final CDC Data Put U.S. Fertility Rate at Record Low ...